Matches in SemOpenAlex for { <https://semopenalex.org/work/W2935892010> ?p ?o ?g. }
- W2935892010 abstract "The purpose of this study is to describe Health-Related Quality of Life (HRQoL) of localized prostate cancer patients in an Active Surveillance (AS) program, and to compare them with those undergoing radical prostatectomy (RP), external-beam radiotherapy (XRT) and brachytherapy (BT). Multi-institutional pooled cross-sectional analysis on patients in an AS protocol: < 75 years old; pathologically confirmed LPC (maximum of three positive cylinders); Gleason score < 3 + 4; clinical stage T1a-T2b; and PSA < 15 ng/ml. Exclusion criteria for this study were: less than 6 months in AS, termination of AS protocol, or incomplete data. Patients in AS were matched with those treated with RP, XRT or BT from the ‘Spanish Multicentric Study of Clinically Localized Prostate Cancer’ cohort according to risk group, time from treatment selection to HRQoL survey, and age. Prostate-specific (EPIC) and generic (SF-36) HRQoL instruments were completed. Analysis was stratified by HRQoL survey moment (>or < 2.5 years from treatment selection), and age (>or < 70 years old). Median of time from treatment selection to HRQoL survey in the total 396 patients (99 per treatment group) was 2.4 years (range 0.5–8.3). Patients in AS presented higher (better) urinary incontinence scores than RP ones in both stratus of time from treatment selection to HRQoL survey (92.6 vs 67.0 and 81.4 vs 64.4, p < 0.01). Patients in AS for < 2.5 years presented greater sexual scores than any active treatment (p < 0.01), but only statistically higher than RP for those in AS for longer than 2.5 years. The magnitude of the differences between AS and RP groups in both EPIC domains ranged from moderate (0.7 SD) to large (1.0 SD). Regardless of treatment applied, patients presented similar and slightly increased SF-36 scores than US general population reference norms. Nonetheless, patients in AS for < 2.5 years reported worse outcomes than other treatment groups on physical health domains, especially in bodily pain (0.5–0.6 SD), and vitality (0.6–0.8 SD). Considering patients’ well-being, AS can be a good therapeutic option due to the low impact caused on urinary continence and sexual function. However, longitudinal studies are required to take into account HRQoL evolution over time." @default.
- W2935892010 created "2019-04-25" @default.
- W2935892010 creator A5006036140 @default.
- W2935892010 creator A5018390077 @default.
- W2935892010 creator A5024771106 @default.
- W2935892010 creator A5030756457 @default.
- W2935892010 creator A5033099455 @default.
- W2935892010 creator A5040197486 @default.
- W2935892010 creator A5057292857 @default.
- W2935892010 creator A5057890308 @default.
- W2935892010 creator A5071922108 @default.
- W2935892010 creator A5082008047 @default.
- W2935892010 creator A5086113203 @default.
- W2935892010 date "2019-01-14" @default.
- W2935892010 modified "2023-10-16" @default.
- W2935892010 title "Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study" @default.
- W2935892010 cites W1264177899 @default.
- W2935892010 cites W1480357620 @default.
- W2935892010 cites W1530769095 @default.
- W2935892010 cites W1540017758 @default.
- W2935892010 cites W1560065148 @default.
- W2935892010 cites W1565117389 @default.
- W2935892010 cites W1700484054 @default.
- W2935892010 cites W1864240211 @default.
- W2935892010 cites W1965672558 @default.
- W2935892010 cites W1978525377 @default.
- W2935892010 cites W1980710500 @default.
- W2935892010 cites W1991146636 @default.
- W2935892010 cites W2031159760 @default.
- W2935892010 cites W2040008722 @default.
- W2935892010 cites W2041853216 @default.
- W2935892010 cites W2064557224 @default.
- W2935892010 cites W2071782474 @default.
- W2935892010 cites W2073484010 @default.
- W2935892010 cites W2091385521 @default.
- W2935892010 cites W2101001966 @default.
- W2935892010 cites W2101995865 @default.
- W2935892010 cites W2106869018 @default.
- W2935892010 cites W2110569728 @default.
- W2935892010 cites W2116113514 @default.
- W2935892010 cites W2117792530 @default.
- W2935892010 cites W2118506138 @default.
- W2935892010 cites W2145567935 @default.
- W2935892010 cites W2159062994 @default.
- W2935892010 cites W2171126362 @default.
- W2935892010 cites W2293122616 @default.
- W2935892010 cites W2519027667 @default.
- W2935892010 cites W2523396458 @default.
- W2935892010 cites W2529652402 @default.
- W2935892010 cites W2582133891 @default.
- W2935892010 cites W2601864730 @default.
- W2935892010 cites W2603592198 @default.
- W2935892010 cites W4254486612 @default.
- W2935892010 cites W4379141712 @default.
- W2935892010 doi "https://doi.org/10.1186/s12955-019-1082-4" @default.
- W2935892010 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6332524" @default.
- W2935892010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30642340" @default.
- W2935892010 hasPublicationYear "2019" @default.
- W2935892010 type Work @default.
- W2935892010 sameAs 2935892010 @default.
- W2935892010 citedByCount "10" @default.
- W2935892010 countsByYear W29358920102019 @default.
- W2935892010 countsByYear W29358920102020 @default.
- W2935892010 countsByYear W29358920102021 @default.
- W2935892010 countsByYear W29358920102022 @default.
- W2935892010 countsByYear W29358920102023 @default.
- W2935892010 crossrefType "journal-article" @default.
- W2935892010 hasAuthorship W2935892010A5006036140 @default.
- W2935892010 hasAuthorship W2935892010A5018390077 @default.
- W2935892010 hasAuthorship W2935892010A5024771106 @default.
- W2935892010 hasAuthorship W2935892010A5030756457 @default.
- W2935892010 hasAuthorship W2935892010A5033099455 @default.
- W2935892010 hasAuthorship W2935892010A5040197486 @default.
- W2935892010 hasAuthorship W2935892010A5057292857 @default.
- W2935892010 hasAuthorship W2935892010A5057890308 @default.
- W2935892010 hasAuthorship W2935892010A5071922108 @default.
- W2935892010 hasAuthorship W2935892010A5082008047 @default.
- W2935892010 hasAuthorship W2935892010A5086113203 @default.
- W2935892010 hasBestOaLocation W29358920101 @default.
- W2935892010 hasConcept C121608353 @default.
- W2935892010 hasConcept C126322002 @default.
- W2935892010 hasConcept C126894567 @default.
- W2935892010 hasConcept C141071460 @default.
- W2935892010 hasConcept C142052008 @default.
- W2935892010 hasConcept C142724271 @default.
- W2935892010 hasConcept C159110408 @default.
- W2935892010 hasConcept C2775908122 @default.
- W2935892010 hasConcept C2776235491 @default.
- W2935892010 hasConcept C2777416452 @default.
- W2935892010 hasConcept C2778531004 @default.
- W2935892010 hasConcept C2779466945 @default.
- W2935892010 hasConcept C2779951463 @default.
- W2935892010 hasConcept C2780192828 @default.
- W2935892010 hasConcept C29456083 @default.
- W2935892010 hasConcept C509974204 @default.
- W2935892010 hasConcept C71924100 @default.
- W2935892010 hasConcept C72563966 @default.
- W2935892010 hasConceptScore W2935892010C121608353 @default.
- W2935892010 hasConceptScore W2935892010C126322002 @default.
- W2935892010 hasConceptScore W2935892010C126894567 @default.